
As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients.
Dr. John Oertle is the Chief Medical Officer of Envita Medical Center — Cancer and Lyme Disease Treatment Experts, lead of the Molecular Tumor Board, as well as residency director at Envita Medical Centers, in Scottsdale, Arizona.